Maple, agreed. hope we see a buyout soon. After three failed CEOs and significant shareholder value destroyed, I've got to believe at this stage the Board recognizes the next best step for the company, it's investors and patients is to sell to a larger entity who can get the platform to market faster and at least make the company's investors and perhaps even a modest ROI.